IC
SAGE

IEQ Capital’s Sage Therapeutics SAGE Stock Holding History

IEQ Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-140,831
Closed -$1.28M – 2041
2025
Q2 		$1.28M Sell
140,831
-23,820
-14% -$175K 0.01% 781
2025
Q1 		$1.31M Buy
164,651
+154,183
+1,473% +$1.13M 0.01% 684
2024
Q4 		$56.8K Buy
+10,468
New +$64K ﹤0.01% 1289

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

IEQ Capital's SAGE Position: Q3 2025 in Review

IEQ Capital sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 140,831 shares — an estimated $1.28M sold.

IEQ Capital first reported a position in SAGE in Q4 2024 and held it in 3 quarters. The position peaked at $1.31M in Q1 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • IEQ Capital reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • IEQ Capital sold 140,831 Sage Therapeutics shares in Q3 2025, an estimated $1.28M.
  • IEQ Capital first reported a position in Sage Therapeutics in Q4 2024 and held it in 3 quarters.
  • IEQ Capital's Sage Therapeutics position peaked at $1.31M in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on IEQ Capital's 13F filing for Q3 2025, filed 14 Nov 2025.